- Report
- February 2025
- 182 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- January 2025
- 183 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- November 2024
- 183 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Report
- October 2025
- 196 Pages
Global
From €3145EUR$3,545USD£2,745GBP
€3495EUR$3,939USD£3,050GBP
- Report
- October 2025
- 196 Pages
Global
From €3145EUR$3,545USD£2,745GBP
€3495EUR$3,939USD£3,050GBP
- Report
- October 2025
- 190 Pages
Global
From €3145EUR$3,545USD£2,745GBP
€3495EUR$3,939USD£3,050GBP
- Report
- October 2025
- 195 Pages
Global
From €3145EUR$3,545USD£2,745GBP
€3495EUR$3,939USD£3,050GBP
- Report
- October 2025
- 191 Pages
Global
From €3145EUR$3,545USD£2,745GBP
€3495EUR$3,939USD£3,050GBP
- Report
- August 2025
- 185 Pages
Global
From €3145EUR$3,545USD£2,745GBP
€3495EUR$3,939USD£3,050GBP
- Report
- August 2025
- 191 Pages
Global
From €3145EUR$3,545USD£2,745GBP
€3495EUR$3,939USD£3,050GBP
- Report
- August 2025
- 188 Pages
Global
From €3145EUR$3,545USD£2,745GBP
€3495EUR$3,939USD£3,050GBP
- Report
- October 2025
- 250 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- October 2025
- 250 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- October 2025
- 250 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- October 2025
- 250 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- October 2025
- 250 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- April 2025
- 175 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- October 2025
- 184 Pages
Global
From €5190EUR$5,850USD£4,530GBP
- Report
- October 2025
- 182 Pages
Global
From €5190EUR$5,850USD£4,530GBP
- Report
- October 2025
- 282 Pages
Global
From €5190EUR$5,850USD£4,530GBP

The Genomics Artificial Intelligence (AI) market is a rapidly growing sector of the genomics industry. It is focused on the development of AI-based solutions to enable the analysis of large-scale genomic data. These solutions are used to identify genetic variants associated with diseases, to develop personalized treatments, and to improve the accuracy of diagnostics. AI-based solutions are also used to identify novel drug targets and to develop new drugs.
The Genomics AI market is driven by the increasing availability of genomic data, the need for more accurate and personalized treatments, and the growing demand for AI-based solutions. The market is expected to continue to grow in the coming years, as more genomic data is collected and AI-based solutions become more widely adopted.
Some companies in the Genomics AI market include Illumina, BGI, Thermo Fisher Scientific, Genomics plc, and DNAnexus. Show Less Read more